<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="Kung University, [6], grid.412717.60000 0004 0532 2914Department of Biotechnology, Southern" exact="Taiwan" post="University of Science and Technology, epub: 2020-6-6110accepted: 2020-6-8(C) ,"/>
 <result pre="23]. In the first randomized and open-label trial conducted in" exact="China" post="among 199 COVID-19 patients treated with ritonavir/lopinavir, no differences"/>
 <result pre="recruited to evaluate the efficacy of favipiravir plus interferon-Î± in" exact="China" post="(ChiCTR2000029600) [33]. Based on the anticipated synergistic effect of"/>
 <result pre="pneumonia [53, 54]. A small open-label non-randomized clinical trial in" exact="France" post="demonstrated a positive effect of HCQ in combination with"/>
 <result pre="HCQ in combination with azithromycin [5]. Upon this finding, although" exact="the US" post="FDA issued an Emergency Use Authorization for hydroxychloroquine in"/>
 <result pre="SARS-CoV-2. Reducing viral copy numbers in SARS-CoV-2; Under debates between" exact="China" post="and France? Anti-malaria. Treatment of rheumatoid arthritis, lupus, and"/>
 <result pre="H, et al. First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med. 2020;382(10):929â€&quot;36. 12.Grein J, Ohmagari N,"/>
 <result pre="et al. First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med. 2020;382(10):929â€&quot;36. 12.Grein J, Ohmagari N,"/>
 <result pre="drugs that may act on the novel coronavirus (2019-nCoV), Wuhan," exact="China" post="through a drug-target interaction deep learning model. bioRxiv. 2020."/>
 <result pre="scabies treatment on the prevalence of head lice in Atoifi" exact="Solomon Islands." post="PLoS Negl Trop Dis. 2018;12(9):e0006825. 43.Beach MJ, Streit TG,"/>
</results>
